NASDAQ
No price data available for this timeframe.
Addus HomeCare Corporation (ADUS) has a consensus Buy rating from 16 analysts with an average price target of $122.00, representing +30.0% upside from the current price of $93.87.
| Date | Analyst | Firm | Target | Price | Upside |
|---|---|---|---|---|---|
| May 15, 2026 | Unknown | Barclays | $92.00 | $92.41 | -0.44% |
| Feb 25, 2026 | Ben Hendrix | RBC Capital | $139.00 | $103.08 | +34.85% |
| Feb 24, 2026 | Unknown | Barclays | $112.00 | $117.63 | -4.79% |
| Jan 7, 2026 | Clarke Murphy | Truist Financial | $135.00 | $110.98 |
May 18, 2026 | Maintained | Citizens | Market Outperform | Market Outperform |
May 15, 2026 | Maintained | Barclays | Underweight | Underweight |
May 6, 2026 | Maintained | Citizens | Market Outperform | Market Outperform |
Mar 25, 2026 | Maintained | Barclays | Underweight | Underweight |
Feb 25, 2026 | Maintained | Stephens & Co. | Overweight | Overweight |
| Nov 4, 2025 | Andrew Mok | Barclays | $117.00 | $118.99 | -1.67% |